ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.33
-0.15 (-1.11%)
At close: Aug 6, 2026, 4:00 PM EDT
13.75
+0.42 (3.15%)
After-hours: Aug 6, 2026, 6:45 PM EDT
ProMIS Neurosciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, ProMIS Neurosciences stock has a consensus rating of "Strong Buy" and an average price target of $39.35. The average 1-year stock price forecast is 195.20% higher than the current stock price, while the lowest is $18.01 (+35.11%) and the highest is $69.33 (+420.11%).
Price Target: $39.35 (+195.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ProMIS Neurosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $35 | Buy | Reiterates | $35 | +162.57% | Jul 29, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $30 | Buy | Reiterates | $30 | +125.06% | Jul 28, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 → $69 | Buy | Maintains | $35 → $69 | +417.63% | Jul 28, 2026 |
| Chardan Capital | Chardan Capital | Buy Initiates $20 | Buy | Initiates | $20 | +50.04% | Jul 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +35.03% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.83
EPS Next Year
-2.39
from -5.83
EPS and Forward PE are based on non-GAAP adjusted numbers.